Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.
Rezaie A, Heimanson Z, McCallum R, Pimentel M.
Rezaie A, et al.
Am J Gastroenterol. 2019 Dec;114(12):1886-1893. doi: 10.14309/ajg.0000000000000444.
Am J Gastroenterol. 2019.
PMID: 31688023
Free PMC article.
The utility of lactulose breath testing (LBT) in predicting response to rifaximin was examined. ...Patients with a positive baseline LBT result experienced significantly greater improvement from baseline in 6 of 7 individual IBS symptoms. LBT re …
The utility of lactulose breath testing (LBT) in predicting response to rifaximin was examined. ...Patients with a posi …